Little is known regarding the role of atopaxar in tumour progression; however, it has been shown to inhibit the Janus kinase-signalling pathway (JAK–STAT), which promotes cell division and neoplastic transformation in cells, thus suggesting a potential role for atopaxar in reducing tumour formation [44]. Here, SOAT1 is linked to neoplasm.